Authors
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Co-pay Accumulator Programs: Behind the ControversyWith ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.
Latest:
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid TumorsEli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) today announced that they have entered into a clinical trial collaboration to evaluate safety and preliminary efficacy of their products.
Latest:
Adult Immunizations: Are Your Patients Up-to-Date?In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
Latest:
Pharmacy Best Practices for Contraceptive Care During COVID-19It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor AgonistNinety percent of diabetes cases are type 2, which is a major cause of morbidity and mortality.
Latest:
Health Technology and the Rise of the E-PatientTechnology has become an essential part of health care.
Latest:
Boehringer Ingelheim Pharmaceuticals' PradaxaPradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.
Latest:
New Antimicrobials Expand Treatment OptionsEravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections
Latest:
Taking Home Gold and the DC Public Health Case ChallengeEach year, the National Academy of Medicine hosts its DC Public Health Case Challenge to promote interdisciplinary, problem-based learning that focuses on an important public health issue facing the Washington, DC community
Latest:
Three Current Policy Discussions Influencing Cancer Drug DevelopmentDespite progress in reducing cancer mortality, more work is needed to improve patient outcomes in this disease state.
Latest:
Securing Specialty Oncology Contracts in a Data-Driven WorldData aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
Latest:
Pharmacists Play an Important Role in Nutrition EducationEducating patients about the nutrition facts label and integrating food pharmacies are examples of pharmacist opportunities.
Latest:
Hereditary Angioedema: The Pharmacist's Role in Team-Based Patient CareAs medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.
Latest:
Ubrelvy: Treatment for Acute Migraines With or Without Aura in AdultsUbrogepant (Ubrelvy, Allergan) was approved for the treatment of acute migraines with or without aura in adults after showing a significantly greater reduction in headache pain compared with placebo.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
Why I Became a Pharmacist: Searching for Cures, Making a DifferenceThe winner of our third annual essay contest shares her story.
Latest:
Training and Education Ensure Safe Handling of Hazardous DrugsBy implementing work practices alongside administrative and engineering controls, a safe and healthy work environment can be achieved.
Latest:
Manufacturer Considerations for Designing a Distribution Strategy for Specialty ProductsThe rising cost of specialty drugs continues to put pressure on all stakeholders. Specialty pharmacists can fill an existing gap in compliance and cost control.
Latest:
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung CancerA national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Latest:
Artificial Intelligence Applications in Education and Pharmacy PracticeBy interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Latest:
Implications of STeP for Improved Diabetes Control: A Payer PerspectiveImplementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.
